STONEPINE CAPITAL MANAGEMENT, LLC Marinus Pharmaceuticals, Inc. Transaction History

STONEPINE CAPITAL MANAGEMENT, LLC portfolio value:

$0
portfolio value

STONEPINE CAPITAL MANAGEMENT, LLC quarter portfolio value change:

+37.40%
quarter

Marinus Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -242.32K shares -1.17M $6.65 0
Q2 2022 share Increase +327.03% 185.58K shares 642K $4.84 242.32K
Q1 2022 share Increase 0.00% 56.74K shares 531K $9.35 56.74K